AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 26, 2026

Half a Century in the Fast Lane: Terry Atamian and Atamian Honda Hits 50 in Tewksbury
SunnyDayz Announces November 21 Grand Opening Celebration Featuring Live Music, Food Trucks, Vendor Pop-Ups & More (21+)
Aptia's Chris Maikels to Speak on Pre-Medicare and Medicare Market Shifts at Consulting Actuaries Annual Meeting
Effort Launched to Make October 30 'Vice Presidents Day'
Northeast Bank Reports First Quarter Results and Declares Dividend
CPS Technologies Schedules Its Q3 Earnings Call
AI Is Reshaping Diabetes Care — From Drug Discovery to Continuous Monitoring
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week
Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management
Nano Dimension Announces Essemtec’s New U.S. Headquarters Amid Accelerating Revenue Growth and Strong Aerospace and Defense Demand
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Amwell® to report third quarter 2026 operating results
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients
Tive Seal Now Available Globally to Help Shippers Detect and Prevent In-Transit Tampering at Scale

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.